Leukocyte-endothelium interactions are diminished in tumors. It is reported here that, in a tumorfree in vivo model, angiogenic factors can down-regulate leukocyte adhesion to endothelium. Slow releasing pellets were loaded with either basic fibroblast growth factor (bFGF), vascular endothelial cell growth factor (VEGF) or vehicle alone and were placed in the scrotum of mice. After 3 days, a single intrascrotal injection of 1 µg/kg IL-1β was given 4 h before vessels of the cremaster muscle were investigated for leukocyte rolling and adhesion by means of intravital microscopy. Exposure of normal tissue to either bFGF or VEGF resulted in markedly decreased levels of cytokine-induced leukocyte adhesion. Suppression of leukocyte rolling was not observed. Instead a moderate enhancement of rolling by VEGF was found. The observed differences could not be explained by differences in fluid dynamic parameters or systemic leukocyte counts. In conclusion, evidence is presented that, in vivo, angiogenic factors significantly reduce leukocyte adhesion, the final step preceding leukocyte infiltration. This observation may explain why tumors escape from immune surveillance.
Introduction
Leukocyte infiltration in tumors has been reported to be elucidated, although several hypotheses exist. A low delivery of leukocytes to the angiogenic microvessels in tumors has associated with improved prognosis (1, 2) . Furthermore, inflammation (3) and immunotherapy (4) have been shown to been described (8,10) as well as a diminished expression of adhesion molecules involved in leukocyte-endothelium be effective for tumor regression. For infiltration from the blood stream into surrounding tissue, leukocytes have to interact interactions in these vessels (11-13). Tumor outgrowth and metastasis are dependent on the with microvascular endothelium. The first interactive step is the slow rolling of leukocytes along the endothelial lining, formation of new vasculature. To achieve this, tumor cells produce high levels of angiogenic factors, such as basic which subsequently may result in firm adhesion, diapedesis and emigration into the surrounding tissue (5,6). Since fibroblast growth factor (bFGF) and vascular endothelial cell growth factor (VEGF). In vitro these factors have been shown leukocyte infiltration may be detrimental to a tumor, escape mechanisms may have evolved to avoid the infiltration of to reduce the expression of endothelial adhesion molecules such as intercellular adhesion molecule (ICAM)-1 (14-16), leukocytes into the tumor. Prevention of leukocyte rolling along or adhesion to endothelium may be such a ICAM-2 and CD34 (17,18). In addition, the cytokineinduced expression of vascular cell adhesion molecule-1 mechanism. Indeed, in several studies leukocyteendothelium interactions, i.e. leukocyte rolling and adhesion, and E-selectin on cultured endothelial cells is markedly inhibited by these pro-angiogenic factors (17). To investigate were found to be reduced in tumor microvessels (7-9). The mechanism behind this reduction has not yet been fully the regulatory function of angiogenic factors on leukocyte-endothelium interactions in vivo, we used a tumor-free model To keep the arterial catheter patent it was continuously perfused with physiological saline (0.5-1 ml/h; Uniflow to avoid complex tumor-associated processes. Pellets slowly releasing angiogenic factors were placed in the mouse system). Mean arterial pressure was continuously recorded on a computer hard disk using a data acquisition system. cremaster muscle and after 3 days cytokine-induced leukocyte-endothelium interactions were analyzed. We provide the Throughout the experiments body temperature was kept at 37°C by means of an IR heating lamp controlled by a thermofirst evidence that both bFGF and VEGF reduce leukocyte adhesion in vivo.
analyzer system connected to a s.c. temperature probe. The cremaster muscle was prepared for intravital microscopy as described previously (21) with an image shearing device (23), while red blood cell unpublished observations).
(RBC) velocity was determined on-line using a prism grating system with the slit covering the whole vessel width (24) . To Animals and experimental protocol obtain actual mean RBC velocities, the measured velocity The experiments were approved by the local ethical committee values were divided by a conversion factor of 1.1 (25) . on the use of laboratory animals. They were performed on Reduced velocity U (mean RBC velocity/vessel diameter), male Swiss mice (Iffa Credo, Someren, the Netherlands), which is a measure of wall shear rate, was calculated from body wt varying from 32 to 39 g. One pellet, filled with either these parameters. 300 ng bFGF (six mice), 300 ng VEGF (six mice) or PBS (four Leukocytes were considered to be rolling if they could be mice) as control, was placed in the scrotum of a halothane seen moving along the vessel wall by eye at a significantly (1.5-2.0% in 80% oxygen) anesthetized mouse on day 0. On lower rate than the blood was flowing. To assure that all rolling day 1 and 2 extra bolus injections of bFGF (30 ng), VEGF leukocytes could be distinguished, the midplane of a vessel (30 ng) or PBS in a volume of about 0.2 ml were given was kept in focus in all experiments (26) . Leukocyte rolling intrascrotally under halothane sedation (4% halothane in 50% was quantified by determining the level of leukocyte rolling as oxygen for 1 min). Each cremaster muscle was exposed to well as the rolling velocity. The level of leukocyte rolling was either bFGF, VEGF or PBS for 3 days, because maximal measured off-line by counting in duplicate the number of adhesion molecule regulation was observed after this period cells that rolled through a predefined segment of the vessel in vitro. In all animals murine recombinant IL-1β (1 µg/kg during a period of 100 s. It was expressed as the number of in 0.2 ml isotonic saline) was injected intrascrotally under rolling cells passing per minute. The velocity of the rolling sedation on day 3, 2.5 h before preparation of the cremaster leukocytes was determined off-line by measuring the median muscle was started. This was performed because leukocyte time taken by 10 randomly chosen rolling leukocytes to travel adhesion is hardly present in the absence of cytokines, which a certain distance along the vessel wall. Leukocytes were would preclude the assessment of a reduction in leukocyte considered to be adherent when they remained stationary for adhesion, if any. at least 30 s. The number of adherent leukocytes present at any instant in a 100 µm segment of the vessel was assessed Intravital microscopy experiments and averaged over a period of 2 min. This parameter was expressed as number of cells per endothelial surface area. Anesthesia was induced with an i.p. injection of sodium pentobarbital (60 mg/kg body wt in a volume of 10 ml/kg),
Values of all parameters were randomly checked by a second observer. The experiments and analyses were performed given under a short halothane sedation (see above) and was maintained by continuous i.v. infusion of sodium pentobarbital blindly. (60 mg/kg/h) through a catheter (pulled PE-10) in the right Systemic leukocyte counts jugular vein. Arterial blood pressure was measured continuously through a catheter in the carotid artery (pulled PE-10;
To perform systemic leukocyte counts, samples of 20 µl blood were collected through the arterial catheter during the Uniflow external pressure transducer; Baxter, Santa Ana, CA). surgical procedure and in some animals also at the end of the experiment. Each blood sample was administered to Tü rks solution (0.2 mg gentian violet in 1 ml glacial acetic acid, 6.25% v/v) in a 1:10 dilution; leukocytes were counted and differentiated as polymorphonuclear (PMN) or monomorphonuclear in a counting chamber (Clay Adams, Parsippany, NJ).
Cells, cultures and immunofluorescence
Mouse SMHEC4 microvascular heart endothelial cells (a kind gift of Dr Auerbach) were cultured in DMEM with 10% FBS supplemented with antibiotics in fibronectin-coated 96-well tissue culture plates. Cells were cultured for 3 days with bFGF (10 ng/ml) or VEGF (30 ng/ml) to investigate their effect on ICAM-1 expression. Culture medium alone was used as a control. After stimulation, endothelial cells were harvested, PharMingen, San Diego, CA) and incubated for 30 min. After two washings cells were incubated with phycoerythrinconjugate and analyzed on a FACSCalibur flow cytometer.
Statistics
Because of their non-symmetrical distribution, most data are presented as medians with interquartile ranges (i.e. the spread from 25th to 75th percentile). Differences between two independent data groups were tested with the MannWhitney U-test; to compare more than two independent data groups the Kruskal-Wallis test was used. In all tests, the level of significance was set at 0.05.
Results

Leukocyte adhesion but not rolling is inhibited by both bFGF and VEGF
After preparation of the cremaster muscle, leukocyte- significantly (P ഛ 0.01) lower than control (i.e. the PBS group) in both the bFGF and the VEGF group ( Fig. 1 ; control, 1068 cells/mm 2 surface area; bFGF, 658/mm 2 ; and VEGF, Fluid dynamic parameters and systemic leukocyte counts 663/mm 2 ).
The level of leukocyte rolling was significantly higher in the In all animals mean arterial blood pressure ranged between 80 and 120 mmHg, which is in the normal range for presence of VEGF (10 cells/min), while bFGF (7 cells/min) had no effect as compared to control (6 cells/min; see anesthetized mice (27) . No major differences in the local fluid dynamic parameters could be detected between the various Fig. 2 ). Leukocyte rolling velocity was slightly higher in the presence of bFGF (median 5 versus 4 µm/s in the control groups (Table 1) , except for a small difference in diameter between the control and VEGF groups. Therefore, it can mice), while VEGF had no effect (4 µm/s; data not shown).
Rolling leukocytes were also present in most of the arterioles be excluded that the differences in leukocyte-endothelium interactions between the groups were caused by differences (in five of the six arterioles observed in the PBS group, four of four in the bFGF group and 17 of 22 in the VEGF group).
in fluid dynamics. Median systemic numbers of leukocytes during the surgical The level of leukocyte rolling was clearly decreased in the bFGF (median 3 cells/min) and VEGF (6.5 cells/min) groups procedure at~3 h after IL-1β injection were not significantly different between the groups (Table 1 ). In the course of the as compared to the PBS group (29 cells/min). Leukocyte rolling velocity was higher in arterioles than in venules: median experiments the systemic number of leukocytes decreased in all animals by~50%. These results indicate that the velocity of 28, 44 and 33 µm/s in the PBS, bFGF and VEGF group respectively. Hardly any adherent leukocytes were differences in leukocyte-endothelium interactions between the groups are not caused by differences in systemic leukoobserved in the arterioles of all groups. this phenomenon is the down-regulation of endothelial cells with either bFGF or VEGF resulted in significant downadhesion molecules. We were not able to demonstrate this regulation of ICAM-1, the predominant adhesion molecule for mechanism in the mouse cremaster venules because adhesion and extravasation of leukocytes, on these cells immunohistochemistry is not sensitive enough to exactly (Table 2 ). This effect resembles the effect of these angiogenic quantify a change in ICAM-1 expression on endothelial cells factors on human endothelial cells.
and, in addition, the mouse cremaster muscle is too small to provide a sufficient number of endothelial cells to perform flow cytometric analysis. We did show, however, that the Discussion expression of ICAM-1 is significantly down-regulated on It has been demonstrated previously that in tumor endocultured mouse endothelial cells, an effect that is similar to thelial cells the expression of adhesion molecules, involved the effect of angiogenic stimulation on human endothelial in leukocyte-endothelium interactions, is suppressed (11-cells and in tumors (15,32). This suggests that the observed 13). In addition, the up-regulation of endothelial adhesion down-regulation of leukocyte adhesion in vivo is caused by molecules in response to inflammatory cytokines in tumors down-regulation of adhesion molecules like ICAM-1. Our was shown to be markedly hampered (17). Exposure of the findings seem to be in contrast with an earlier study by Melder endothelial cells to tumor-derived factors appeared to be et al., which suggested that bFGF and VEGF have opposite responsible for these phenomena (14,15). Since this knowfunctions with regard to leukocyte adhesion (16). While bFGF ledge is exclusively based on studies that were performed inhibited adhesion both in vitro and in vivo, the effect of VEGF in vitro, we developed a model to selectively study the effects was only investigated in vitro with human umbilical vascular of single tumor-derived factors on leukocyte-endothelium endothelial cells that were cultured without serum. by firm adhesion.
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In our cremaster preparations, leukocyte rolling was also In conclusion, the mouse cremaster muscle is a practical 
